Search results
Appearance
- ...t established immunotherapy as the new standard of care in 2020.<ref name="fda-nivo-ipi" /> Today, researchers are exploring CAR-T cell therapy, gene ther ...18 months or longer with modern multimodal treatment approaches. The 2020 FDA approval of nivolumab plus ipilimumab marked the first new systemic therapy ...38 KB (4,762 words) - 23:25, 14 May 2026
- ...c classification 2024, talc cancer evidence, Johnson Johnson talc verdict, FDA talc testing, talc asbestos contamination ...assification system, 67,115 pending lawsuits, $2.5B+ in 2025 verdicts, and FDA regulatory gaps. ...58 KB (7,890 words) - 05:05, 25 May 2026
- ...ucts from 1930s hair dryers to modern talc cosmetics. Covers CPSC recalls, FDA testing, J&J litigation, EPA bans, and testing methods. ...ion, asbestos hair dryers, Johnson and Johnson talc, asbestos baby powder, FDA talc testing, CPSC asbestos recall, asbestos popcorn ceiling, asbestos floo ...65 KB (8,450 words) - 23:24, 14 May 2026
- ...-support tool; not yet standard of care; not Food and Drug Administration (FDA)-cleared as a companion diagnostic; not covered by Medicare or private insu ...e checkpoint inhibitor regimens:''' nivolumab + ipilimumab (CheckMate 743, FDA-approved first-line October 2020) and pembrolizumab + pemetrexed/platinum c ...36 KB (4,576 words) - 21:55, 25 May 2026
- == Asbestos Regulations & Ban History == * [[US Asbestos Ban History and Regulations]] — Hub: full regulatory timeline from 1930s cover-ups to the 2024 chrysoti ...25 KB (2,946 words) - 12:40, 21 May 2026
- ...ely justified why a comprehensive ban was less burdensome than alternative regulations.<ref name="1989_ban_reversal" /> The Lautenberg Act removed this obstacle. Legal analysis by Danziger & De Llano indicates that in November 2025, the FDA withdrew its proposed rule banning talc powder contaminated with asbestos, ...25 KB (3,346 words) - 14:15, 25 April 2026
- | '''Mesothelin Biomarker Accuracy''' || 61% sensitivity, 87% specificity; FDA-approved diagnostic marker<ref name="biomarkerdata" /> ...' || Immunotherapy median OS 18.1 months vs. 14.1 months for chemotherapy; FDA approved October 2020<ref name="checkmate743" /> ...43 KB (5,359 words) - 23:24, 14 May 2026
- * '''Biomarker sensitivity vs. imaging''' — the only FDA-cleared mesothelioma blood test (MESOMARK) detects just 32% of cases at 95% ...0px; border-bottom:1px solid #555;" | 32% sensitivity at 95% specificity — FDA-cleared for monitoring, not population screening ...50 KB (6,457 words) - 23:24, 14 May 2026
- | style="padding:10px; border-bottom:1px solid #dee2e6;" | '''FDA-Approved Systemic Regimens''' ...ssay (measuring soluble mesothelin-related peptides/SMRP) remains the only FDA-approved blood biomarker, cleared in 2007 for monitoring treatment response ...62 KB (7,842 words) - 23:25, 14 May 2026
- ...tps://www.epa.gov/asbestos/asbestos-laws-and-regulations Asbestos Laws and Regulations], U.S. Environmental Protection Agency</ref> (2) '''Consumer products''' av * Regulatory oversight: Minimal FDA/EPA/CPSC oversight of asbestos products before 1973 ...68 KB (8,792 words) - 19:39, 20 May 2026
- | Immunotherapy / year || $150,000–$200,000 || Annual cost of FDA-approved immunotherapy (nivolumab + ipilimumab, CheckMate 743 regimen) ...nistration (MSHA) and Occupational Safety and Health Administration (OSHA) regulations specific to talc are expected to be reviewed in light of the IARC ruling. ...27 KB (3,536 words) - 17:04, 15 May 2026
- | Immunotherapy / year || $150,000–$200,000 || Annual cost of FDA-approved immunotherapy (nivolumab + ipilimumab, CheckMate 743 regimen) ...specified in federal Occupational Safety and Health Administration (OSHA) regulations. Federal asbestos rules historically focused on chrysotile, crocidolite, am ...33 KB (4,287 words) - 13:48, 15 May 2026
- ...ival to 18.8 months, though this remains off-label. September 2024 brought FDA approval of pembrolizumab combined with chemotherapy, offering improved 3-y ...ost important chemotherapy agent for mesothelioma treatment since its 2004 FDA approval for first-line use in combination with platinum-based agents. ...218 KB (26,785 words) - 23:07, 14 May 2026